Has Karthik Gonuguntla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,678 in general payments to Karthik Gonuguntla, MD across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karthik Gonuguntla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karthik Gonuguntla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karthik Gonuguntla, MD

Cardiovascular Disease · Norwich, CTNPI 1073019667

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.7%), grants and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 45.0% of the total. Reporting peaked in 2024 at $1,434 and has fallen 84.2% since, to $227 in 2025.

$2,678in general payments, 2019–2025

Across 43 payments — averaging $62.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$647
Abbott$281
Medtronic$170
Amgen$170
Kiniksa Pharmaceuticals International, PLC$67
plus $138 from 4 others

What the payments were for

Grants$1,06340%
Food & beverage$1,14343%
Education$47118%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	2	$1,204
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	26	$647
Abbott	2	$281
Medtronic	2	$170
Amgen	3	$170
Kiniksa Pharmaceuticals International, PLC	2	$67
E.r. Squibb & Sons, L.L.C.	2	$49
Novo Nordisk	2	$38
Baxter Healthcare	1	$28
Lantheus Medical Imaging, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THORATEC HEARTMATE 3 LVAS IMPLANT KIT$265
WATCHMAN FLX$141
Repatha$120
COREVALVE EVOLUT R$116

How this compares

$2,678 in reported general payments places this provider in the 65th percentile of 415 cardiovascular disease providers in Connecticut.

See all cardiovascular disease providers in Connecticut →

Medicare billing

Part B allowed, 2024

$51,433

Medicare patients

665

Services billed

1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	25	$31,666
JardianceEmpagliflozin	17	$26,412
Repatha SureclickEvolocumab	14	$10,977
Metoprolol Succinate	68	$992
Atorvastatin Calcium	80	$754
Ezetimibe	33	$500
Rosuvastatin Calcium	36	$395
Lisinopril	36	$233
Losartan Potassium	15	$150
Carvedilol	15	$149
Isosorbide Mononitrate ErIsosorbide Mononitrate	19	$141
Diltiazem 24hr Er (Cd)Diltiazem Hcl	14	$129
Furosemide	23	$97
Amlodipine Besylate	26	$85
ClopidogrelClopidogrel Bisulfate	15	$68

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Norwich

Nihar DesaiNew Haven$1.4M
Brett NowlanBloomfield$798K
Jeffery TestaniNew Haven$546K
Carlos Mena-HurtadoNew Haven$460K
Stephanie SaucierHartford$243K
John ForrestNew Haven$164K
Henry WardNew Haven$152K
Ricardo CordidoHamden$135K
Antonio FernandezHartford$113K
Paul ThompsonHartford$108K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →